baber/WOPTO huggingface dataset:
Patent NZ-259370-A (NZ)
Title: Method of manufacturing insulation panels of shredded paper or card mixed with an additive including adhesive and fire-retardent and a water repellant or absorbent, or mildew or corrosion inhibitant etc and compressed or molded at an additive melting temperature into panels
Inventor: DE SANTI PIERO
IPC: B29B17/00
Filed: 1993-12-23
Abstract: Manufacturing process of panels or finished products, particularly for thermic, sound and similar insulation, by using raw materials like the paper, the Bristol board, the cardboard and similar materials, which are in succession or at deferred times cut to obtain particles with reduced dimensions, mixed to fire-retardant, adhesives, and bonding agents, and additives of various types and compressed at heated or cooled conditions and finally dried and packed. There are described different possibilities of performing the process and different embodiments as well as use modes of the so obtained panels or finished products.
Patent NZ-272015-A (NZ)
Title: Treatment of insufficiency of central choline functions using a cyclic amide (substituted 1,3-benzoxazin-2-one derivative)
Inventor: SUGIMOTO HACHIRO
IPC: C07D498/04
Filed: 1991-06-13
Abstract: The cyclic amide derivative is defined by the formula (I) or a  salt thereof: R1-(CH2)n-Z in which R1 is a group derived from a cyclic amide compound, substituted or unsubstituted, n is zero or an integer of 1 to 10 and Z is <CHEM> R2 being an aryl, a substituted aryl, a cycloalkyl or a heterocyclic group, m being an integer of 1 to 6, R3 being hydrogen or a lower alkyl, R4 being an aryl or a substituted aryl, a cycloalkyl or a heterocyclic group, p being an integer of 1 to 6, provided that the cyclic amide compound is quinazoline-on or quinazoline-dion, R2 and R4 are neither aryl nor substituted aryl. The cyclic amide compound is pharmacologically effective to prevent and treat diseases due to insufficiency of the central choline functions.
Patent NZ-272610-A (NZ)
Title: The manufacture of dispersible tablets containing fluoxetine by direct compression
Inventor: MENDIZABAL FLAVIA ARCE
IPC: A61K47/38
Filed: 1995-07-19
Abstract: Pharmaceutical formulations of fluoxetine or an acid addition salt thereof, suitable for manufacturing dispersible tablets by direct compression and comprising, in addition to the active ingredient, the appropriate excipients and coadjuvants, selected from among disintegrants, diluents, lubricants, anti-adherents, sweeteners, flavorings and, optionally, colorants.Said formulations are suitable for manufacturing dispersible tablets which disintegrate in less than three minutes in water at 19•C - 21•C, and are appropriate for treatment of depression.
Patent NZ-274278-A (NZ)
Title: Making spheroidal granules of an inhalable medicament powder by agglomerating, spheronising, then sizing
Inventor: TROFAST EVA
IPC: B01J2/00
Filed: 1994-09-29
Abstract: A method of treating a finely divided powder is provided including a) forcing the powder through the apertures of a sieve to form agglomerates; and b) spheronizing the agglomerates. The method results in spheronized agglomerates having sufficient strength to withstand processing and packaging operations, but which are sufficiently soft to deagglomerate during delivery via a breath-actuated inhaler.
Patent NZ-308842-A (NZ)
Title: Method and apparatus for copy protection for various recording media using a video fingerprint
Inventor: RYAN JOHN O
IPC: G06F21/10
Filed: 1996-05-22
Abstract: A method and apparatus for copyright protection for various recording media such as Digital Video Discs (DVDs) uses a combination of a Video Finger Print Signal and an Authenticating Signature to permit the player to handle either copy-protected or non-copy-protected media, in a manner that is difficult to compromise.  Both a Video Finger Print Signal and an Authenticating Signature are recorded on the media only when copy-protection is required. The nature of this Authenticating Signature is such that it will not be transferred to illicit copies made on CD recorders.  When either an original protected or an original non-protected disk is played, the presence or absence of the Authenticating Signature causes the player to correctly play the program video. All original DVDs therefore play normally. When a copy of a non-protected CD is played, the absence of the Video Print Signal also causes the player to correcly playback the video signal data.  However, when a copy of a protected CD is played, the absence of the Authenticating Signature causes the player to prohibit the disk from playing normally.
Patent NZ-332308-A (NZ)
Title: 2-piperidylamino-4-amino pyrimidine derivates as dopamine d4 receptor antagonists
Inventor: BOSMANS JEAN-PAUL RENE MARIE A
IPC: C07D401/12
Filed: 1997-05-02
Abstract: The present invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein Alk is C1-6alkanediyl or C3-6alkenediyl; R1 is hydrogen or C1-4alkyl; R2 and R3 each independently are hydrogen, C1-6alkyl or C3-7cycloalkyl; or R2 and R3 may also be taken together with the nitrogen atom to which they are attached, thus forming a pyrrolidine, a piperidine or a perhydro azepine ring; R4 is hydrogen or halo; Q is aryl, aryloxy, di(aryl)methyl or heteroaryl; aryl is naphthyl or phenyl, said naphthyl and phenyl may optionally be substituted; and heteroaryl is quinolinyl, isoquinolinyl, pyridinyl, thienyl, indolyl, 2,3-dihydro-1,4-benzodioxinyl, 2,3-dihydro-benzofuranyl or benzodioxolanyl; said heteroaryls may optionally be substituted; it further relates to processes for their preparation, compositions comprising them as well as their use as a medicine; compounds of formula (I) containing a radioactive isotope; a process of marking dopamine D4 receptor sites; and a process for imaging an organ are disclosed.
Patent NZ-333579-A (NZ)
Title: Aqueous formulations of peptides, preferably LHRH
Inventor: ECKENHOFF JAMES B
IPC: A61K38/09
Filed: 1997-07-01
Abstract: This specification describes stable liquid aqueous formulations of peptide compounds at high concentrations. These stable formulations comprise at least about 10 % peptide in water. They may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug.  Preferred peptides include leuprolide, LHRH, nafarelin and goserelin.
Patent NZ-333990-A (NZ)
Title: Method of attenuating viruses that do not bind to brain membrane receptor preparations
Inventor: BARRETT ALAN
IPC: G01N33/566
Filed: 1998-06-08
Abstract: A method of selecting virus vaccine candidates that do not bind to brain membrane receptor preparations, comprising the steps of: (a) preparing a brain membrane receptor preparation; (b) mixing a virus with the membrane receptor preparation containing excess membrane receptors to form a virus-membrane receptor preparation suspension; (c) centrifuging the suspension to form a supernatant; (d) determining residual virus infectivity in the supernatant; and (e) isolating individual membrane receptor preparation binding-resistant virus variants.
Patent NZ-337433-A (NZ)
Title: Removal of surface material from a road work surface using an abrasive applicator and housing
Inventor: JONES RHYS ALEXANDER
IPC: E01C19/22
Filed: 1999-08-24
Abstract: An abrasive applicator assembly for the removal of surface material from a work surface includes a containment portion 2 in the form of a bottomless housing whose internal volume encompasses an area of the work surface and includes a peripheral sealing skirt 10 about its open bottom portion.  A nozzle set 5 comprises a plurality of abrasive applicator nozzles directable towards the work surface within the area encompassed by containment portion 2.  The nozzle is connected or connectable to means 22 for supplying and propelling abrasive material therethrough.  The nozzles are mounted to a drive movable platform capable of movement within a plane parallel to the work surface thereby allowing the associated nozzles to be positioned to direct abrasive material onto different areas within the area encompassed by containment portion 2.  At least one exhaust port 11 in containment portion 2 is connected or connectable to vacuum means for the withdrawal of air and other matter from within containment portion 2.
Patent NZ-500537-A (NZ)
Title: Solid compositions suitable for oral administration comprising non-hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
Inventor: SCAFETTA NAZARENO
IPC: A23L33/00
Filed: 1998-03-19
Abstract: The stable and non-hygroscopic salts of L-carnitine or lower alkanoyl-L-carnitine with 2-aminoethanesulfonic acid, of formula (I), are suitable for preparing solid compositions useful as dietary/nutritional supplements for human use and as fodder supplement for veterinary purposes.   In formula (I), R is acetyl, propionyl, butyryl, valeryl or isovaleryl.
Patent NZ-502907-A (NZ)
Title: Implantable device comprising outer encasement of polysaccharide and inner gel for tissue regeneration
Inventor: HANSSON HANS-ARNE
IPC: A61L31/00
Filed: 1997-04-01
Abstract: An implantable device for promoting growth of nerve tissue regenerate into a wound area of an organized tissue in a human or animal from the wound area in a predetermined direction comprising: a) an outer encasement structure for the device to be implanted, b) an inner gel structure with one or more guide channels for tissue regenerate so when the device is implanted in the encased wound such that the guide channels extend in the predetermined direction, where each guide channel has a cross-sectional dimensional in the range of 150-500ìm.
Patent NZ-505610-A (NZ)
Title: A direct expansion contact heat exchanger
Inventor: CLARGES RUSSELL ANTHONY
IPC: F28D21/00
Filed: 1999-01-20
Abstract: A direct expansion contact heat exchanger (10) which has a plurality of inter-connected overlapping heat exchange elements (14). The heat exchange elements are removably located within a housing (11). The housing (11) has an inlet (15) and an outlet (16) so that in use the flow of fluid through the housing (11) between adjacent overlapping heat exchange elements (14) can occur. The heat exchange elements (14) are connectable to heat exchange medium via an inlet (18) and an outlet (19). The heat exchange elements (14) can be substantially disc shaped with a sector thereof removed.
Patent NZ-507201-A (NZ)
Title: Topical hormonal composition with systemic effect
Inventor: LANQUENTIN MICHEL
IPC: A61P15/00
Filed: 1999-03-23
Abstract: A gelled and/or film forming hormonal composition for treating hormonal disorders such as progesterone deficiency in pre-menopausal women and a hormone replacement in menopausal women is disclosed, which comprises: 0.05 to 1% by wt. Of the total composition of at least one active substance selected from the group consisting of nomegestrol and ethers and esters thereof; at least one vehicle allowing systematic passage of the active substance, the vehicle being a solubilising agent, an absorption promoter, a film forming agent, a gelling agent and optionally a diluent.
Patent NZ-509124-A (NZ)
Title: Resistive reusable electrosurgical return electrode
Inventor: KIEDA DAVID B
IPC: A61B18/08
Filed: 1999-07-20
Abstract: The reusable electrosurgical return electrode pad (41) is for use with electrosurgery. In one embodiment it includes a presentation or working surface area lying in a range of from about 100 square centimetres to about 20,000. In another, the working surface is at least as large as that of a projection of about half of the profile of the trunk of a patient. In yet another, it includes a working surface area at least as large as that of a projection of the profile of both the trunk and legs of a patient. It is adapted for disposition on the working surface of an operating table or dentist's chair immediately underlying a patient during electrosurgery. By presenting a very large working surface area, the need for direct contact or contact through conducting gels is eliminated; through employment of washable surface areas, it is made readily cleanable and reusable; and through the selection of resistance characteristics for the electrode materials of the principal body of the electrode. Through tailoring of electrode geometries, it is made self-limiting as to current density, and temperature rise so as to prevent patient trauma. An optional sleeve is provided for cooperative use with the electrode.
Patent NZ-512967-A (NZ)
Title: Presentation software and method of providing a presentation to a user of an internet web browser
Inventor: LOEPER DAVID B
IPC: H04N1/00
Filed: 2000-04-03
Abstract: A method for providing a presentation (60) to a user of the Internet web browser (110), by directing the browser  to access  preselected Internet resources  (50),  such  as  web pages,  in  a preselected order, while preventing  the  user from  employing the browser to move to resources other  than those  selected,  or to change the order of presentation  is disclosed.  Modifications may be provided to the content  of the  Internet resources as received by the user, as well  as additional  content.  The method may include  for  real-time creation of a presentation; such real-time creation  may  be used  while  in  communication,  such  as  by  telephone  or another  method,  so  that the composer  and  recipient  may simultaneously  view  the selected Internet  resources.  The presentation may be in the form of a file that  is  readable by  a  general-purpose  web browser, without  the  need  for specialized  software.  The  presentation  file  provides  a series  of  commands to the browser running  on  the  user's computer   to  create  the  presentation.  The  presentation displays  the  current  content of various  preselected  web sites   for   a   selected  time  in   a   selected   order, modifications   of   such  content,  and   presentation   of additional  textual, graphic, and auditory  content.  During the   presentation,  the  browser  is  connecting   to   and receiving  information  from web  sites  or  other  Internet resources.  During the presentation, the user cannot  access links on the web sites or other Internet resources, so  that the  particular  displayed resources are controlled  by  the presentation.
Patent NZ-518094-A (NZ)
Title: Process for preparing N-acylamino compounds
Inventor: BATCHELOR MARK J
IPC: A61P31/04
Filed: 1996-12-20
Abstract: Disclosed are pyradazino[1,2-a][1,2]diazepine-1-carboxamide compounds of formula R1N(h)R', which are inhibitors of interleukin-1beta converting enzyme.
Patent NZ-521530-A (NZ)
Title: Transaction handling methods and systems
Inventor: KOREN RONI
IPC: G06Q30/00
Filed: 2001-03-23
Abstract: A transaction method is disclosed which includes the steps of (a) registering at least one available transaction, (b) assigning to the available transaction a transaction code which is publicised, (c) registering at least one user, where registering includes recording payment information from the user, (d) assigning a personal identification code to the user, (e) accepting automatically an aural communication which includes the personal identification code and the transaction code, and (f) arranging at least one available transaction to be completed for the user, including arranging to have payment collected based on the recorded payment information.
Patent NZ-521875-A (NZ)
Title: Fuel additive compositions for fuels for internal combustion engines with improved viscosity properties and good IVD performance
Inventor: SCHWAHN HARALD
IPC: C10L1/195
Filed: 2001-05-04
Abstract: A fuel additive composition contains at least one detergent, a carrier oil mixture comprising at least one synthetic carrier oil having a viscosity of from about 120 to about 270 mm2/s, determined at +20oC according to DIN 51562, part 1, and at least on mineral carrier oil having a viscosity of form about 250 to about 410 mm2/s determined at +20oC according to DIN 51562, part 1, and if required further conventional fuel additive components. Preferably the mineral oil carrier is selected from kerosene, naptha, brightstock, base oils having viscosities from class SN 500-2000, aromatic hydrocarbons, paraffinic hydrocarbons, alkoxyalkanols and hydrocrack oil and mixtures thereof and the synthetic carrier oil is selected from polyolefins, (poly) esters, (poly)alkoxylates, polyethers, aliphatic polyetheramines, alkylphenol-initiated polyethers, alkylphenol-initiated polyetheramines and carboxylic esters of long-chain alkanols or mixtures thereof.
Patent NZ-522464-A (NZ)
Title: Control of power drawn by loads supplied by inductive power transfer systems using pick-up means and switch means
Inventor: BOYS JOHN TALBOT
IPC: H02J5/00
Filed: 2002-11-07
Abstract: An inductive power distribution system that comprises: (a) An alternating current electric power supply; (b) A primary conductive path connected to the electric power supply; (c) At least one electric device being for use in conjunction with the primary conductive path, the device being capable of deriving at least some power from a magnetic field associated with the primary conductive path; (d) The device including at least one pick-up means comprising a resonant circuit having a pick-up resonant frequency at or near the alternating power supply frequency; (e) At least one output load capable of being driven by electric power induced in the pick-up means; (f) Cyclically operable switch means operable at a frequency substantially differing from the power supply to reduce the power transferred from the primary conductive path to the pick-up means; (g) Control means to operate the switch means to control the transfer of power from the primary conductive path to the pick-up means; and (h) Characterised in that the control means is operable to limit the power transferred from the primary conductive path by controlling the mark-space ratio of the switch.
Patent NZ-523881-A (NZ)
Title: Saline/sewage water reclamation system
Inventor: BITTERLY JACK G
IPC: C02F1/08
Filed: 2001-07-18
Abstract: Disclosed is a water reclamation system (30) includes a series of concentric thin shells including outer shell (40), intermediate shell (32), and inner shell (34). The shells mount within a housing (50) that can be maintained under vacuum or low pressure. The shells rotate at high velocity. Contaminated liquid from outside the housing is injected into the space between half the shells. The centrifugal force causes the liquid to form a thin film along the inward facing surface of the shell. A compressor (220) lowers the pressure adjacent the thin film causing the liquid to boil. The compressor carries the vapor to the other side of those shells at a slightly higher temperature. There the vapor encounters the wall, which is cooler because its heat was transferred to boil the contaminated liquid. The vapor condenses, and rotation throws the condensate against the adjacent wall where it is collected. When condensing, the heat of condensation transfers to the shell for boiling the incoming contaminated liquid. The system (30) needs no heat sources other than the energy of vapor compression to complete the cycle flow from vaporization to condensation.
Patent NZ-524051-A (NZ)
Title: A method for treating proteinaceous fibres
Inventor: BUCHERT JOHANNA
IPC: D06M16/00
Filed: 2001-08-15
Abstract: A method for enzymatic treatment of proteinaceous fibres, comprising contacting protein fibre, selected form the group of wool, wool fibre, non-human animal hair, silk or spidersilk, with an aqueous solution comprising tyrosinase enzyme under conditions suitable for the function of the enzyme resulting in oxidation of tyrosinase residues in proteinaceous fibres. The tyrosine enzyme may originate from various sources, such as from plant, animal or microbial origin.
Patent NZ-525858-A (NZ)
Title: M. tuberculosis chaperonin 60.1 and uses thereof
Inventor: COATES ANTHONY ROBERT MILNES
IPC: A61P17/02
Filed: 2001-11-16
Abstract: A compound comprising a nucleic acid molecule comprising the nucleotide sequence of Figure 1, a sequence which has at least 70% identity to the sequence of Figure 1, a sequence that hybridizes to the sequence which encodes a functionally equivalent protein to the sequence encoded by the nucleotide sequence of Figure 1or a functionally equivalent fragment thereof or a polypeptide comprising the amino acid sequence of Figure 1 or a sequence that has at least 70% homology to the sequence of Figure 1 and provides a functionally equivalent protein is used in the manufacture of a medicament for the prevention and/or treatment of autoimmune disorders, allergic conditions and/or respiratory diseases or for stimulating cytokine production. Preferably the condition is selected from asthma or arthritis. Also described is an adjuvant system comprising the nucleotide or polypeptide sequence of Figure 1 and an antigen.
Patent NZ-526686-A (NZ)
Title: A wood steaming apparatus and method of heating wood
Inventor: GIBBS PETER
IPC: B27L5/00
Filed: 2001-12-20
Abstract: A wood steaming apparatus for heating wood (4) within chamber (1). Water within trough (8) is heated to generate "wet steam". Condensate is collected in collector (10) and pumped by pump (11) back to trough (8). The use of "wet steam" results in relatively uniform heating whilst maintaining relatively consistent moisture content throughout the wood. The closed loop design minimises the production of polluting condensate waste.
Patent NZ-528315-A (NZ)
Title: Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as MGLUR2 antagonists II
Inventor: ADAM GEO
IPC: A61P25/18
Filed: 2002-04-02
Abstract: Dihydro-benzo [b] [1,4] diazepin-2-one derivatives which are of general formula I and are mGluR2 antagonists II are disclosed. A medicament comprising these compounds and a process for preparing them is also disclosed. The compounds are useful in the treatment or prevention of neurological disorders including psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits.
Patent NZ-528839-A (NZ)
Title: Antihistaminic piperidine derivatives and intermediates
IPC: A61K31/445
Filed: 1999-06-17
Abstract: A process for the preparation of substantially pure [4-(4-halo-1-oxybutyl)]-N-methoxy-N-methyl-benzeneacetamide of formula (I) is disclosed, wherein X is Cl, Br or I these compounds are suitable as intermediates in the synthesis of antihistaminic piperidine derivatives. (62) Divided Out of 508477
Patent NZ-533635-A (NZ)
Title: Expression vectors and promoters for heterologous gene expression
Inventor: KELLY ANDREW GRAHAM
IPC: C07K14/47
Filed: 2002-12-23
Abstract: Described is a vector comprising a promoter which can be operably linked to a gene encoding a heterologous protein, and which induces expression of any operably linked heterologous protein. Required is the presence of nucleotides which may or may not have a phosphate group, and the promoter sequence to be a xapA promoter. The xapA promoter comprises ribosomal binding site having the following sequence: AGGAGG xxxxx or AGGAGG xxxxxx or AGGAGA xxxxx or AGGAGA xxxxxx Also described are expression vectors utilising elements of the xanthosine operon and methods for the production of heterologous proteins.